About Cytel
Cytel news and updates
Cytel Inc. acquires Purple Squirrel Economics
Cytel Inc., a leading provider of advanced analytics for the life sciences industry, has announced the acquisition of Purple Squirrel Economics.
Jan 1, 2020 | healtheconomics.comCytel Inc. hires Albert Kim as Chief Medical Officer
Cytel Inc. has appointed Albert Kim, MD, PhD, as its first Chief Medical Officer (CMO), driving expansion of the advanced analytics capabilities avail...
Jan 1, 2022 | lifesciencenewswire.comCytel Inc. receives award 2021 Trial of the Year Award
Cytel has been granted the Society for Clinical Trials’ (SCT) 2021 Trial of the Year Award for TOGETHER, an adaptive platform trial designed to expedite evaluation of nearly a dozen cost-effective COVID-19 therapies for low- and middle-income countries.
Jan 1, 2022 | centerwatch.comCytel Inc. expanded offices to Tulsa, Oklahoma, United States on Sep 6th 22'.
Cytel Inc. has expanded its operations into the Asia-Pacific region (APAC).
Sep 5, 2022 | clinicalresearchnewsonline.comCytel Inc. acquires Sdslifescience
U.S.-based Cytel Inc. has entered into an agreement to acquire Scandinavian companies SDS Life Sciences AB and SDS MedeQ AB.
Oct 13, 2022 | labiotech.euCytel Inc. launched East Bayes on Mar 1st 21'.
In March 2021, Cytel Inc. launched East® Bayes, an enhanced web-based extension of the East® platform that enables the adoption of the most computationally intensive Bayesian clinical trial designs – without the need for powerful on-site computers.
Nov 22, 2022 | yahoo.com